Hot Features
Premium
Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Período:
Tipo de Línea:
| Volume | 189,319 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 0.79 | Mínimo Máximo |
|||||
| Minimo del Dia | 0.733 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Virpax Pharmaceuticals Inc | VRPX | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.011 | -1.41% | 0.77 | 18:56:57 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.79 | 0.733 | 0.79 | 0.7731 | 0.781 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 637 | 189,319 | US$ 0.7605578 | US$ 143,988 | - | 0.68 - 11.774 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 18:56:57 | formt | 100 | US$ 0.77 | USD |
Información Financiera Virpax Pharmaceuticals Inc VRPX
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 890.29k | 1.17M | - | 0 | -15.19M | -12.97 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Virpax Pharmaceuticals Inc VRPX
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 17/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16/5/2024 | 15:00 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 15/5/2024 | 07:00 | Business Wire | Virpax Announces Pricing of $2.25 Million Public Offering |
| 14/5/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 13/5/2024 | 16:30 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 13/5/2024 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13/5/2024 | 15:10 | Business Wire | Virpax Pharmaceuticals Reports 2024 First Quarter Results.. |
| 13/5/2024 | 15:02 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 30/4/2024 | 06:30 | Business Wire | Virpax Announces Results of Maximum Tolerated Dose Study for.. |
| 26/3/2024 | 06:30 | Business Wire | Virpax Pharmaceuticals Reports 2023 Year-End Results |
| 27/2/2024 | 06:31 | Business Wire | Virpax Pharmaceuticals Announces Reverse Stock Split to.. |
| 27/2/2024 | 06:30 | Business Wire | Virpax Pharmaceuticals Announces Proposed Settlement of.. |
Histórico de Datos VRPX
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.55 | 3.14 | 0.68 | 0.8641094 | 729,517 | -1.78 | -69.80% |
| 1 Month | 3.55 | 3.6472 | 0.68 | 0.9652438 | 193,667 | -2.78 | -78.31% |
| 3 Months | 3.49 | 5.48 | 0.68 | 1.90 | 93,530 | -2.72 | -77.94% |
| 6 Months | 7.101 | 7.199 | 0.68 | 3.33 | 199,811 | -6.33 | -89.16% |
| 1 Year | 7.70 | 11.774 | 0.68 | 4.04 | 114,144 | -6.93 | -90.00% |
| 3 Years | 39.90 | 359.799 | 0.68 | 103.17 | 716,356 | -39.13 | -98.07% |
| 5 Years | 80.00 | 359.799 | 0.68 | 102.10 | 673,064 | -79.23 | -99.04% |
